Trends and outcomes in the treatment of gliomas based on data during 2001-2004 from the Brain Tumor Registry of Japan

Neurologia Medico-chirurgica
Yoshitaka NaritaCommittee of Brain Tumor Registry of Japan Supported by the Japan Neurosurgical Society

Abstract

The committee of Brain Tumor Registry of Japan (BTRJ) was founded in 1973 and conducts surveys and analyses of incidence, therapeutic methods, and treatment outcomes of primary and metastatic brain tumors with the cooperation of the Japan Neurosurgical Society members. Newly diagnosed 3,000-4,000 primary brain tumors and 600-1,000 brain metastases patients were enrolled in each year. This report describes the trends and treatment outcomes of gliomas from BTRJ volume 13, including 13,431 patients with primary brain tumors who newly started treatment from 2001 to 2004. Data from 382 diffuse astrocytomas (DAs), 121 oligodendrogliomas (OLs), 90 oligoastrocytomas (OAs), 513 anaplastic astrocytomas (AAs), 126 anaplastic oligodendrogliomas (AOs), 106 anaplastic oligoastrocytomas (AOAs), and 1,489 glioblastomas (GBMs) were analyzed for overall survival (OS) and progression free survival (PFS) depending on age, symptoms, Karnofsky performance status, location of the tumor, extent of resection (EOR), initial radiotherapy and chemotherapy. The 5-year PFS rates of the patients with DA, OL+OA, AA, AO+AOA, and GBM were 57.0%, 74.6%, 28.7%, 54.0%, and 9.2%, and the 5-year OS rates were 75.0%, 90.0%, 41.1%, 68.2%, and 10.1%, respectively. High...Continue Reading

References

Mar 27, 1999·Neurologia Medico-chirurgica
Sep 1, 1959·Journal of Neurosurgery·S KATSURAT WADA
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Sep 20, 2005·Lancet·M J van den BentUNKNOWN EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council
Apr 14, 2007·Journal of Neuro-oncology·Luc BauchetFrançois Segnarbieux
Apr 17, 2007·Journal of Neurosurgery·Thomas J SemradRichard H White
Apr 17, 2007·Lancet Neurology·Melanie S M van BreemenCharles J Vecht
Jul 10, 2007·Acta Neuropathologica·David N LouisPaul Kleihues
Feb 5, 2008·Journal of Neurosurgery·Edward F ChangMitchel S Berger
Mar 8, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Justin S SmithMitchel S Berger
Mar 28, 2008·Journal of Neuro-oncology·Santosh KesariAmy A Pruitt
Feb 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alba A BrandesMario Ermani
Mar 31, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joachim CohenLuc Deliens
Sep 22, 2010·Journal of Korean Neurosurgical Society·Chang-Hyun LeeSeung Hoon Lee
Jan 18, 2011·International Journal of Clinical Oncology·Hideo NakamuraUNKNOWN Kumamoto Brain Tumor Research Group
Mar 23, 2011·Journal of Neurosurgery·Nader SanaiMitchel S Berger
Oct 18, 2011·Journal of Neurosurgery·Matthew B PottsMitchel S Berger
Apr 25, 2012·Current Atherosclerosis Reports·Alan J VelanderBabak B Navi
Jan 29, 2013·Journal of Neuro-oncology·Reena P ThomasSeema Nagpal
Apr 1, 2013·Brain Tumor Research and Treatment·Kyu-Won JungHeon Yoo

❮ Previous
Next ❯

Citations

May 16, 2015·Acta Neuropathologica·Koichi IchimuraCynthia E Hawkins
Apr 16, 2016·Journal of Neurosurgery·Shunya OhtakiOsamu Honmou
Mar 7, 2015·Neurologia Medico-chirurgica·Makoto Shibuya
Nov 5, 2019·Journal of Global Oncology·Fabio GirardiMichel P Coleman
Feb 18, 2016·The International Journal of Biostatistics·Asanao ShimokawaEtsuo Miyaoka
Feb 13, 2016·Oncology Letters·Hiroki NambaTomohiro Yamasaki
Nov 14, 2020·European Journal of Cancer Care·Edna KeeneyWilliam Hollingworth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.